1. Home
  2. /
  3. Availability
  4. /
  5. Modelling the health and economic impacts of M72/AS01E vaccination and BCG-revaccination: estimates for South Africa

Modelling the health and economic impacts of M72/AS01E vaccination and BCG-revaccination: estimates for South Africa

Description

we used a mathematical model to estimate the health impact and cost-effectiveness of M72/AS01E and BCG-revaccination in South Africa under a range of vaccine characteristics and delivery assumptions
TB vaccine theme
Availability
Economic impact/cost-effectivenss, Epidemiological impact

Project details

Country
South Africa
Timeline
2023
Target group
Adolescents, General Adults
Vaccine
BCG revaccination, M72/AS01e
Type of protection of vaccine
Prevention of disease, Prevention of infection
Type of research
Modelling
Partners involved
BMGF, Boston University, Harvard University, KNCV, LSHTM, University of Cape Town
Type of project
research
Funder
Civil Society
Governmental Body

Resources

Modelling the health and economic impacts of M72/AS01E vaccination and BCG-revaccination: estimates for South Africa | medRxiv

Contact

Tom Sumner
tom.sumner@lshtm.ac.uk
Click to copy link of this header Menu